FIGURE 4.

(A) Number and types of cardiac events reported post COVID‐19 vaccinations in 98 studies including those by Pottegård et al. and excluding those by Smadja et al. (reported separately). A total of 50 CI events were reported after receiving Pfizer vaccine (32 myocarditis, 3 myocardial infarction (MI), 11 myopericarditis and 4 others, including 2 pericarditis, 1 acute coronary syndrome (ACS) and 1 stress cardiomyopathy). Twenty‐five cases of cardiac events were detected in individuals post Moderna vaccination (24 myocarditis and 1 MI). Seventy‐four cardiac events were reported in individuals who received the AstraZeneca vaccine (23 MI, 46 ischemic heart disease and 5 others, including 1 heart strain, 1 cardiac arrest and 3 ACS). Only 1 case of myocarditis was reported post J&J vaccination and 1 case of Kounis syndrome type 1 variant reported after receiving the CoronaVac vaccine. (B) Number of cases of MI (associated with arterial thrombosis) in individuals who received Pfizer, Moderna and AstraZeneca vaccine as reported by Smadja et al. The cases represent 20%, 21.5% and 13.9% of the total cases of thrombosis following Pfizer, Moderna and AstraZeneca vaccines, respectively